Amiodarone Hydrochloride (CAS 19774-82-4) is a well-known and widely used anti-arrhythmic API that plays a critical role in cardiovascular therapy. It belongs to class III anti-arrhythmic agents and is indicated for serious ventricular and supraventricular arrhythmias.
At TCS GROUP, we offer Amiodarone Hydrochloride with stringent quality controls, GMP-grade documentation and full traceability. Our supply supports tablet, capsule and injectable developers seeking a trusted partner for cardiovascular API supply.
Key features & formulation considerations
- Highly lipophilic molecule with a long half-life, enabling sustained therapeutic impact.
- Suitable for immediate-release and extended-release dosage forms; formulators must address solubility and stability challenges.
- Compliance with regulatory dossiers (EP/USP standards) and reliable sourcing are essential for market launch.
Why partner with TCS INDUSTRIES LIMITED?
- Consistent supply chain and documentation support for global markets.
- Integration with other API or excipient systems: for example, if combining Amiodarone Hydrochloride with high-efficiency excipients such as our Microcrystalline Cellulose – Premium Filler & Binder for Direct Compression, you ensure reliable tablet architecture and performance.
- Complementary API portfolio: consider our Ademetionine Disulfate Tosylate (CAS 97540-22-2) for hepatology or combination therapy platforms.
By selecting Amiodarone Hydrochloride from TCS GROUP, you are choosing a foundation for therapeutic innovation in cardiology with regulatory-ready supply, robust technical support and market-focused manufacturing excellence.